In the ATAC trial, the following characteristics were found to be associated with increased risk of development of toxicity on both univariate and multivariate analysis prior chemotherapy, prior hormone replacement therapy, body mass index BMI 30 kg m 2, patient location in North America or the United Kingdom, and overexpression of estrogen receptors on tumor specimens

مهمان عزیز شما حق دیدن لینک ها را ندارید برای استفاده از امکانات کامل انجمن عضو شوید

عضویت